Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 3/20 | 0.66 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.66 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.62 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.62 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.59 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | LCK | P06239 | 1/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.50 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.50 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.45 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19025453 | 1.00 | GRIK1 (0.66) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL3970104 | 1.00 | GRIK1 (0.66) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL9514740 | 1.00 | GRIK1 (0.66) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL3969952 | 1.00 | GRIK1 (0.66) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL3964378 | 1.00 | GRIK1 (0.66) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL23071647 | 1.00 | GRIK1 (0.66) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL3968580 | 1.00 | GRIK1 (0.66) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL3964189 | 1.00 | GRIK1 (0.66) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL19025278 | 1.00 | GRIK1 (0.66) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL8536214 | 1.00 | GRIK1 (0.66) | GRIK1GRIK2SLC1A2SLC1A1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170183595-A1 | LOW VISCOSITY LOW VOLATILITY LUBRICATING OIL BASE STOCKS AND METHODS OF USE THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-29 | — | — | US | claimed |
| EP-3397737-A2 | LOW VISCOSITY LOW VOLATILITY LUBRICATING OIL BASE STOCKS AND METHODS OF USE THEREOF | ExxonMobil Research and Engineering Company (US) | 2018-11-07 | — | — | EP | disclosed |
| US-10077409-B2 | Low viscosity low volatility lubricating oil base stocks and methods of use thereof | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2018-09-18 | — | — | US | disclosed |
| WO-2017116899-A2 | LOW VISCOSITY LOW VOLATILITY LUBRICATING OIL BASE STOCKS AND METHODS OF USE THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2017-07-06 | — | — | WO | disclosed |
| US-20170183595-A1 | LOW VISCOSITY LOW VOLATILITY LUBRICATING OIL BASE STOCKS AND METHODS OF USE THEREOF | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-29 | — | — | US | disclosed |
| WO-2003095407-A2 | 2,4-DIALKYL-BRANCHED ALDEHYDES AND DERIVATIVES PRODUCED THEREFROM | SASOL GERMANY GMBH (DE) | 2003-11-20 | — | — | WO | disclosed |
| EP-1335915-A2 | TETRAHYDROBENZAZEPINE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS (ANTIPSYCHOTIC AGENTS) | SMITHKLINE BEECHAM PLC (GB) | 2003-08-20 | — | — | EP | disclosed |
| WO-2002040471-A2 | TETRAHYDROBENZAZEPINE DERIVATIVES USEFUL AS MODULATORS OF DOPAMINE D3 RECEPTORS (ANTIPSYCHOTIC AGENTS) | SMITHKLINE BEECHAM P.L.C. (GB) | 2002-05-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10077409-B2 | Low viscosity low volatility lubricating oil base stocks and methods of use thereof | F12, POLH, STK33 | GRIK1 3949/4885GRIK2 4082/4885SLC1A2 4635/4885 |
| US-20170183595-A1 | LOW VISCOSITY LOW VOLATILITY LUBRICATING OIL BASE STOCKS AND METHODS OF USE THEREOF | F12, POLH, STK33 | GRIK1 3949/4885GRIK2 4082/4885SLC1A2 4635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.